Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ochi A"'
Autor:
Hiroyuki Ochi, Yoshihiko Hosokawa, Azusa Akiyama, Nobutaka Tasaka, Takeo Minaguchi, Keiko Nishida, Manabu Sakurai, Ayumi Shikama, Kaoru Fujieda, Toyomi Satoh
Publikováno v:
Oncology Letters
Type II endometrial carcinoma mainly originates from p53 aberration. However, the detailed prognostic significance of p53 aberration in endometrial carcinoma remains to be clarified. In the present study, abnormal p53 accumulation was analyzed using
Autor:
Yusuke Okubo, Kojiro Kobayashi, Takayuki Mori, Masataka Yoneda, Takeshi Kenmochi, Yasukiyo Sumino, Nobuhiro Tsukamoto, Hiroyuki Makino, Yoshinori Igarashi, Kazuhiro Fuchinoue, Takashi Ikehara, Kazue Shiozawa, Manabu Watanabe, Yuta Suzuki, Yuta Ochi
Publikováno v:
Oncology Letters
The CyberKnife® is expected to be a novel local treatment for hepatocellular carcinoma (HCC), however, a long-term follow-up using dynamic computed tomography and magnetic resonance imaging is required to determine the effect of treatment in a numbe
Autor:
Kazuhiko Nishimura, Naoki Sakuyama, Tsuyoshi Sato, Tomoo Watanabe, Isao Nagaoka, Satomi Mashiko, Takashi Inou, Shunji Futagawa, Kenji Kishine, Takumi Ochiai, Hideki Orikasa, Satoshi Ookubo, Takanori Ochi, Marie Washio, Masayuki Kitajima, Akinori Nakatani
Publikováno v:
Oncology Letters. 3:269-272
The effectiveness of cetuximab (Cmab) against KRAS p.G13D mutant-type tumors has been reported. In this study, we report a case of metastatic ascending colon cancer harboring a KRAS p.G13D mutation in a 65-year-old female. Considering the absence of
Autor:
Isao Nagaoka, Kazuhiko Nishimura, Marie Washio, Akinori Nakatani, Satomi Mashiko, Tsuyoshi Sato, Satoshi Okubo, Masayuki Kitajima, Kenji Kishine, Takumi Ochiai, Tomoo Watanabe, Takanori Ochi, Shunji Futagawa, Naoki Sakuyama, Takashi Inou
Publikováno v:
Oncology letters. 4(4)
The leucovorin (FOL) and fluorouracil (5-FU) plus oxaliplatin (l-OHP; FOLFOX) or FOL and 5-FU plus irinotecan (SN-38; FOLFIRI) regimens with or without molecularly-targeted drugs are widely used as first-line chemotherapy in the treatment of advanced
Autor:
Misa Ichiryu, Aki Hasebe, Masanori Abe, Atsushi Tanabe, Masashi Hirooka, Nayu Tazuya, Kojiro Michitaka, Hironori Ochi, Yasunao Miyamoto, Hiromasa Nakahara, Yoichi Hiasa, Tomoyuki Ninomiya, Atsushi Hiraoka, Satoshi Hidaka, Soichi Ichikawa, Morikazu Onji, Bunzo Matsuura, Takahide Uehara
Publikováno v:
Oncology letters. 1(1)
Some hepatocellular carcinoma (HCC) nodules are detectable with dynamic computed tomography, but not by conventional B-mode ultrasonography (US). Contrast-enhanced US (CEUS) with Sonazoid, a new injectable contrast agent, has been used in Japan since